178 related articles for article (PubMed ID: 22233694)
1. Altered levels of fecal chromogranins and secretogranins in IBS: relevance for pathophysiology and symptoms?
Ohman L; Stridsberg M; Isaksson S; Jerlstad P; Simrén M
Am J Gastroenterol; 2012 Mar; 107(3):440-7. PubMed ID: 22233694
[TBL] [Abstract][Full Text] [Related]
2. Fecal chromogranins and secretogranins are increased in patients with ulcerative colitis but are not associated with disease activity.
Strid H; Simrén M; Lasson A; Isaksson S; Stridsberg M; Öhman L
J Crohns Colitis; 2013 Dec; 7(12):e615-22. PubMed ID: 23694857
[TBL] [Abstract][Full Text] [Related]
3. Evidence of increased fecal granins in children with irritable bowel syndrome and correlates with symptoms.
Shulman RJ; Öhman L; Stridsberg M; Cain K; Simrén M; Heitkemper M
Neurogastroenterol Motil; 2019 Jan; 31(1):e13486. PubMed ID: 30298961
[TBL] [Abstract][Full Text] [Related]
4. Fecal chromogranins and secretogranins are linked to the fecal and mucosal intestinal bacterial composition of IBS patients and healthy subjects.
Sundin J; Stridsberg M; Tap J; Derrien M; Le Nevé B; Doré J; Törnblom H; Simrén M; Öhman L
Sci Rep; 2018 Nov; 8(1):16821. PubMed ID: 30429499
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
6. Colonic transit time and IBS symptoms: what's the link?
Törnblom H; Van Oudenhove L; Sadik R; Abrahamsson H; Tack J; Simrén M
Am J Gastroenterol; 2012 May; 107(5):754-60. PubMed ID: 22334251
[TBL] [Abstract][Full Text] [Related]
7. Fecal Calprotectin and serum chromogranin A as potential biomarkers of irritable bowel syndrome symptom severity.
Pletikosic S; Plavsic I; Hauser G; Tkalcic M
Med Hypotheses; 2015 Sep; 85(3):339-42. PubMed ID: 26112162
[TBL] [Abstract][Full Text] [Related]
8. Editorial: fecal granins in IBS: cause or indicator of intestinal or colonic irritation?
Camilleri M
Am J Gastroenterol; 2012 Mar; 107(3):448-50. PubMed ID: 22388024
[TBL] [Abstract][Full Text] [Related]
9. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome.
Silberer H; Küppers B; Mickisch O; Baniewicz W; Drescher M; Traber L; Kempf A; Schmidt-Gayk H
Clin Lab; 2005; 51(3-4):117-26. PubMed ID: 15819166
[TBL] [Abstract][Full Text] [Related]
10. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
Langhorst J; Junge A; Rueffer A; Wehkamp J; Foell D; Michalsen A; Musial F; Dobos GJ
Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795
[TBL] [Abstract][Full Text] [Related]
11. Different segmental transit times in patients with irritable bowel syndrome and "normal" colonic transit time: is there a correlation with symptoms?
Bouchoucha M; Devroede G; Dorval E; Faye A; Arhan P; Arsac M
Tech Coloproctol; 2006 Dec; 10(4):287-96. PubMed ID: 17115321
[TBL] [Abstract][Full Text] [Related]
12. Fecal assays detect hypersensitivity to cow's milk protein and gluten in adults with irritable bowel syndrome.
Carroccio A; Brusca I; Mansueto P; Soresi M; D'Alcamo A; Ambrosiano G; Pepe I; Iacono G; Lospalluti ML; La Chiusa SM; Di Fede G
Clin Gastroenterol Hepatol; 2011 Nov; 9(11):965-971.e3. PubMed ID: 21839707
[TBL] [Abstract][Full Text] [Related]
13. Role of fecal calprotectin in the diagnosis and treatment of segmental colitis associated with diverticulosis.
Tursi A; Elisei W; Giorgetti G; Aiello F; Brandimarte G
Minerva Gastroenterol Dietol; 2011 Sep; 57(3):247-55. PubMed ID: 21769075
[TBL] [Abstract][Full Text] [Related]
14. Calprotectin in ankylosing spondylitis--frequently elevated in feces, but normal in serum.
Klingberg E; Carlsten H; Hilme E; Hedberg M; Forsblad-d'Elia H
Scand J Gastroenterol; 2012 Apr; 47(4):435-44. PubMed ID: 22229862
[TBL] [Abstract][Full Text] [Related]
15. Fecal calprotectin as a predictor of abnormal colonic histology.
Shitrit AB; Braverman D; Stankiewics H; Shitrit D; Peled N; Paz K
Dis Colon Rectum; 2007 Dec; 50(12):2188-93. PubMed ID: 17963005
[TBL] [Abstract][Full Text] [Related]
16. Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome.
Shin A; Camilleri M; Vijayvargiya P; Busciglio I; Burton D; Ryks M; Rhoten D; Lueke A; Saenger A; Girtman A; Zinsmeister AR
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1270-1275.e1. PubMed ID: 23639599
[TBL] [Abstract][Full Text] [Related]
17. Altered rectal perception in irritable bowel syndrome is associated with symptom severity.
Posserud I; Syrous A; Lindström L; Tack J; Abrahamsson H; Simrén M
Gastroenterology; 2007 Oct; 133(4):1113-23. PubMed ID: 17919487
[TBL] [Abstract][Full Text] [Related]
18. Effects of chili on postprandial gastrointestinal symptoms in diarrhoea predominant irritable bowel syndrome: evidence for capsaicin-sensitive visceral nociception hypersensitivity.
Gonlachanvit S; Mahayosnond A; Kullavanijaya P
Neurogastroenterol Motil; 2009 Jan; 21(1):23-32. PubMed ID: 18647268
[TBL] [Abstract][Full Text] [Related]
19. Heightened colon motor activity measured by a wireless capsule in patients with constipation: relation to colon transit and IBS.
Hasler WL; Saad RJ; Rao SS; Wilding GE; Parkman HP; Koch KL; McCallum RW; Kuo B; Sarosiek I; Sitrin MD; Semler JR; Chey WD
Am J Physiol Gastrointest Liver Physiol; 2009 Dec; 297(6):G1107-14. PubMed ID: 19808653
[TBL] [Abstract][Full Text] [Related]
20. Symptom severity but not psychopathology predicts visceral hypersensitivity in irritable bowel syndrome.
van der Veek PP; Van Rood YR; Masclee AA
Clin Gastroenterol Hepatol; 2008 Mar; 6(3):321-8. PubMed ID: 18258487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
